Pretreatment with PB (30 mg/kg) and glycitin [F (5, 30) = 8.997, P = 0.0039] at the doses of 5, 10 and 20 mg/kg (P = 0.0026, P = 0.0262, P = 0.0146, and P = 0.0145 respectively, Figure 5A) remarkably reduced the MDA level in comparison with the CN group
Stacy M.
Exogenous treatment with Agm has also proven to be protective in a number of neurodegenerative contexts, including epilepsy, stroke, and age-related dementias (Xu et al., 2018)
The use of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity contributes to the steady reduction of the main clinical and biochemical symptoms of nonalcoholic steatohepatitis
Adequate Sleep: Prioritize quality sleep, as it is during sleep that the body undergoes various repair and regeneration processes, including the synthesis of glutathione